Diabetes in a high secure hospital
暂无分享,去创建一个
D. Finnegan | G. Gill | J. Pinkney | I. MacFarlane | G. Gill
[1] D. Grobbee,et al. Antipsychotic drugs may worsen metabolic control in type 2 diabetes mellitus. , 2004, The Journal of clinical psychiatry.
[2] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.
[3] E. Koller,et al. Clozapine-associated diabetes. , 2001, The American journal of medicine.
[4] K. Cruickshank,et al. High prevalence of type 2 diabetes in all ethnic groups, including Europeans, in a British inner city: relative poverty, history, inactivity, or 21st century Europe? , 2001, Diabetes care.
[5] T. Valle,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.
[6] C. Bogardus,et al. Changing habits to delay diabetes. , 2001, The New England journal of medicine.
[7] G. Tollefson,et al. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. , 2001, The Journal of clinical psychiatry.
[8] A. Astrup,et al. Obesity : Preventing and managing the global epidemic , 2000 .
[9] H. Gin,et al. Diabetes as a result of atypical anti‐psychotic drugs – a report of three cases , 2000, Diabetic medicine : a journal of the British Diabetic Association.
[10] D. Goff,et al. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study. , 2000, The American journal of psychiatry.
[11] N. Beeching,et al. Capture-recapture-adjusted prevalence rates of type 2 diabetes are related to social deprivation. , 1999, QJM : monthly journal of the Association of Physicians.
[12] S. Marder,et al. Novel antipsychotics and new onset diabetes , 1998, Biological Psychiatry.
[13] L. Nolan,et al. Bodyweight Gain Induced by Psychotropic Drugs , 1998 .
[14] J. Peters,et al. NHS acute sector expenditure for diabetes: the present, future, and excess in‐patient cost of care , 1997, Diabetic medicine : a journal of the British Diabetic Association.
[15] J. Peters,et al. Patterns of In and Out‐patient Activity for Diabetes: a District Survey , 1996, Diabetic medicine : a journal of the British Diabetic Association.
[16] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[17] E. Masson,et al. An Audit of the Management and Outcome of Hospital Inpatients With Diabetes: Resource Planning Implications for the Diabetes Care Team , 1992, Diabetic medicine : a journal of the British Diabetic Association.
[18] E. Masson,et al. Diabetes in prison: can good diabetic care be achieved? , 1992, BMJ.
[19] C. Fraser,et al. Problems of diabetics in prison , 1989, BMJ.
[20] H. McKee,et al. DIABETES AND SCHIZOPHRENIA—A PRELIMINARY STUDY , 1986, Journal of clinical and hospital pharmacy.
[21] F. Brambilla,et al. Glucose-insulin metabolism in chronic schizophrenia. , 1976, Diseases of the nervous system.
[22] W. Lorenz. SUGAR TOLERANCE IN DEMENTIA PRAECOX AND OTHER MENTAL DISORDERS , 1922 .
[23] F. Kooy. HYPERGLYÆMIA IN MENTAL DISORDERS , 1919 .
[24] N. Sicolo,et al. Effect of chlorpromazine on blood glucose and plasma insulin in man , 2004, European Journal of Clinical Pharmacology.
[25] Anson,et al. DIET , LIFESTYLE , AND THE RISK OF TYPE 2 DIABETES MELLITUS IN WOMEN , 2001 .
[26] L. Dixon,et al. Prevalence and correlates of diabetes in national schizophrenia samples. , 2000, Schizophrenia bulletin.
[27] P. Decina,et al. Diabetes mellitus in schizophrenic patients. , 1996, Comprehensive psychiatry.
[28] P. Cowen,et al. Practical problems in clinical psychiatry , 1992 .
[29] S. Colagiuri,et al. The Diabetes Control and Complications Trial , 1983, Henry Ford Hospital medical journal.